Purchase Order 75N93025P00086
Award Date
12/16/24
Potential Completion Date
12/15/25
Potential Value
$48K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for the procurement of Illumina NextSeq, NovaSeq, and Nextera sequencing systems and associated kits. The contract has a ceiling value of $44,228.22 and a period of performance through December 31, 2024. This order is not set aside for any special business categories. Illumina is an established provider of genomic sequencing instruments...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. for the procurement of an Illumina NextSeq 2000 sequencing system with a trade-in. The total ceiling value of the award is $207,415.25 and the ultimate completion date is October 4, 2024. The contract does not have any set-aside designation. Based on Illumina's background as a manufacturer of genetic and genomic analysis instruments and reagents, this award is likely...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a High Throughput Sequencing System. The contract has a ceiling value of $289,365.00 and was awarded on September 12, 2016, with a final completion date of October 28, 2016. The contract does not have a set-aside designation. Illumina, Inc. is a manufacturer and provider of...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract provides for the supply of reagents, kits, and supplies to support Illumina's 2000 and 4000 sequencing systems. The contract has a ceiling value of $99,939.56 and an ultimate completion date of March 3, 2021. Illumina has previously held other prime federal contracts and sub-grants...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the basic product care maintenance of a NextSeq S/N NSS00515 sequencing system, including a 4-year service plan. The total ceiling value of the contract is $137,565.03. Illumina, a manufacturer of DNA sequencing instruments and reagents, has previously received other prime...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $4,037.50, is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. The contract has no set-aside designation....
This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of various Next Generation Sequencing (NGS) systems, reagents, and services. The contract, valued at $69,240.04, does not have a set-aside designation and runs through September 29, 2025. Illumina has previously supported genomic sequencing and analysis needs across multiple federal...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of consumables to support Illumina's genetic sequencing equipment. The contract has a total ceiling value of $108,694.36 and a completion date of November 16, 2021. Illumina is a manufacturer of sequencing and analysis solutions for life science research, applied markets, and molecular...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract, valued at $91,472.77, is for the provision of reagents and consumables to support Illumina's sequencing platforms, including NextSeq, NovaSeq, MiSeq, and iSeq systems. This appears to be a standing purchase order without a...